Carter Todd Alfred 4
4 · Voyager Therapeutics, Inc. · Filed Jul 10, 2023
Insider Transaction Report
Form 4
Carter Todd Alfred
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-06$10.80/sh−5,500$59,400→ 59,860 total
Footnotes (1)
- [F1]The reported sale of 5,500 shares occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 31, 2023.